References

Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future

10.1016/j.cell.2017.01.018 · 2017 · External reference

Clonal evolution in cancer

10.1038/nature10762 · 2012 · External reference

Cancer genome landscapes

10.1126/science.1235122 · 2013 · External reference

The Evolution of Mouse Models of Cancer: Past, Present, and Future

10.1101/cshperspect.a041736 · 2025 · External reference

A genetic model for colorectal tumorigenesis

10.1016/0092-8674(90)90186-i · 1990 · External reference

A Big Bang model of human colorectal tumor growth

10.1038/ng.3214 · 2015 · External reference

Conditional reverse tet-transactivator mouse strains for the efficient induction of TRE-regulated transgenes in mice

10.1371/journal.pone.0095236 · 2014 · External reference

Rapid and specific degradation of endogenous proteins in mouse models using auxin-inducible degrons

10.7554/elife.77987 · 2022 · External reference

Somatic activation of the K-ras oncogene causes early onset lung cancer in mice

10.1038/35074129 · 2001 · External reference

MmCMS: mouse models' consensus molecular subtypes of colorectal cancer

10.1038/s41416-023-02157-6 · 2023 · External reference

The consensus molecular subtypes of colorectal cancer

10.1038/nm.3967 · 2015 · External reference

Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis

10.1016/j.ccell.2019.08.003 · 2019 · External reference

NOX1 and NPY1R mark regional colon stem cell populations that serve as cancer origins in vivo

10.1038/s41556-025-01763-1 · 2025 · External reference

Oncogenic BRAF, unrestrained by TGFbeta-receptor signalling, drives right-sided colonic tumorigenesis

10.1038/s41467-021-23717-5 · 2021 · External reference

MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance

10.1038/s41586-025-09916-w · 2026 · External reference

Difference Between Left-Sided and Right-Sided Colorectal Cancer: A Focused Review of Literature

10.14740/gr1062w · 2018 · External reference

Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer

10.1038/s41588-024-01654-5 · 2024 · External reference

Nucleophosmin supports WNT-driven hyperproliferation and tumor initiation

10.1038/s41588-025-02408-7 · 2026 · External reference

Polyclonality overcomes fitness barriers in Apc-driven tumorigenesis

10.1038/s41586-024-08053-0 · 2024 · External reference

Dynamic and adaptive cancer stem cell population admixture in colorectal neoplasia

10.1016/j.stem.2022.07.008 · 2022 · External reference

Unraveling Pancreatic Cancer: Epidemiology, Risk Factors, and Global Trends

2024 · External reference

Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice

10.1016/j.ccr.2005.04.023 · 2005 · External reference

Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer

10.1158/2159-8290.cd-24-0177 · 2024 · External reference

Pancreatic cancer: Advances and challenges

10.1016/j.cell.2023.02.014 · 2023 · External reference

KRAS Inhibitors in Pancreas Cancer: Facts and Hopes about the Immunotherapy We've All Been Waiting For

10.1158/1078-0432.ccr-25-0821 · 2026 · External reference

Response and Resistance to RAS Inhibition in Cancer

10.1158/2159-8290.cd-25-0349 · 2025 · External reference

Dual Recombinase-Based Mouse Models Help Decipher Cancer Biology and Targets for Therapy

10.1158/0008-5472.can-22-2119 · 2023 · External reference

Type I collagen deletion in alphaSMA(+) myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer

10.1016/j.ccell.2021.02.007 · 2021 · External reference

Human-correlated genetic models identify precision therapy for liver cancer

10.1038/s41586-025-08585-z · 2025 · External reference

Co-inhibition of TGF-beta and PD-L1 pathways in a metastatic colorectal cancer mouse model triggers interferon responses, innate cells and T cells, alongside metabolic changes and tumor resistance

10.1080/2162402x.2024.2330194 · 2024 · External reference

Clinically relevant orthotopic pancreatic cancer models for adoptive T cell transfer therapy

10.1136/jitc-2023-008086 · 2024 · External reference

Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche

10.1038/nature07935 · 2009 · External reference

Organoid models of human and mouse ductal pancreatic cancer

10.1016/j.cell.2014.12.021 · 2015 · External reference

Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer

10.1084/jem.20162024 · 2017 · External reference

Loss of colonic fidelity enables multilineage plasticity and metastasis

10.1038/s41586-025-09125-5 · 2025 · External reference

An Intrasplenic Injection Model for the Study of Cancer Stem Cell Seeding Capacity

10.1007/978-1-0716-0747-3_20 · 2020 · External reference

A Plastic EMP1+ to LGR5+ Cell State Conversion as a Bypass to KRASG12D Pharmacologic Inhibition in Metastatic Colorectal Cancer

10.1158/2159-8290.cd-25-0679 · 2026 · External reference

Metastatic recurrence in colorectal cancer arises from residual EMP1(+) cells

10.1038/s41586-022-05402-9 · 2022 · External reference

A preclinical mouse model of invasive lobular breast cancer metastasis

10.1158/0008-5472.can-11-4208 · 2013 · External reference

Mutational scanning reveals oncogenic CTNNB1 mutations have diverse effects on signaling

10.1038/s41588-025-02496-5 · 2026 · External reference

Hepatic zonation determines tumorigenic potential of mutant beta-catenin

10.1038/s41586-025-09733-1 · 2026 · External reference

Senescence induction dictates response to chemo- and immunotherapy in preclinical models of ovarian cancer

10.1073/pnas.2117754119 · 2022 · External reference

Development of an ObLiGaRe Doxycycline Inducible Cas9 system for pre-clinical cancer drug discovery

10.1038/s41467-020-18548-9 · 2020 · External reference

A prime editor mouse to model a broad spectrum of somatic mutations in vivo

10.1038/s41587-023-01783-y · 2024 · External reference

CRISPR-mediated modeling and functional validation of candidate tumor suppressor genes in small cell lung cancer

10.1073/pnas.1821893117 · 2020 · External reference

The auxin-inducible degron 2 technology provides sharp degradation control in yeast, mammalian cells, and mice

10.1038/s41467-020-19532-z · 2020 · External reference

Development of an inducible mouse model of iRFP713 to track recombinase activity and tumour development in vivo

10.1038/s41598-017-01741-0 · 2017 · External reference

The differential effects of mutant p53 alleles on advanced murine lung cancer

10.1158/0008-5472.can-05-2193 · 2005 · External reference